We must look both “upstream” – at advocating for change on an institutional level – and “downstream” – at what we can do as individuals to help women secure the care they need.

The post To Continue the Momentum in Women’s Health, We Have No Time to Lose appeared first on MedCity News.

Certain features, commonplace on most e-commerce platforms, can help transform clinical trial search databases.

The post Search, Click, Enroll? What Clinical Trials Can Learn from E-commerce appeared first on MedCity News.

Without taking specific steps to improve trial diversity, advances in inclusive treatments will continue at a snail’s pace.

The post Five Strategies To Boost Clinical Trial Diversity appeared first on MedCity News.

By leveraging analytics to optimize the patient experience in clinical trials, patient attrition will decrease, improving clinical outcomes and research goals.

The post Alleviating Patient Burden in Clinical Trials: Modeling a Consumer-Grade Experience appeared first on MedCity News.

Atropos Health and Seqster joined forces to address historical diversity and inclusion challenges in clinical trials. The partnership seeks to enable the swift creation of turnkey patient registries that generate real world evidence from existing registries in under 48 hours.

The post Atropos Health, Seqster Team Up to Reduce Disparities in Clinical Trials appeared first on MedCity News.

It’s critical that we address these examples of institutionalized bias and racism in how we approach clinical trials for drugs and devices. While it’s a daunting task, the path forward is surprisingly clear, and AI can be instrumental in the next step of overcoming unconscious biases inherent in clinical trial processes.

The post Health Equity Begins with Increasing Diversity in Clinical Research: AI Can Help appeared first on MedCity News.

Inato recently raised $20 million in Series A2 funding for its tech platform, which enables access to inclusive clinical trials. The two-way platform brings exposure to community-based providers who often are overlooked by Big Pharma for clinical trial sites by allowing providers to apply for clinical trials in which they’re interested.

The post Inato Snags $20M to Make Clinical Trials More Diverse & Accessible appeared first on MedCity News.

Wearable patient devices can provide healthcare organizations with more varied data, expand options for clinical trials, and make patients more active participants in their own care.

The post How Patient Monitoring Is Poised to Revolutionize Healthcare appeared first on MedCity News.

Clinical research as a care option is a means of connecting patients with clinical research as part of their ongoing health care, located where they receive that care, and offered by their trusted provider.

The post Putting Patients First: Seeking To Solve Long-standing Challenges With Clinical Research Participation and Access appeared first on MedCity News.

Gen Z is the most diverse, digitally-proficient generation yet. Gen Z MSLs have the skills and power to change the future of healthcare by using technology to redefine who KOLs are, how they are engaged, and ultimately, how clinical trials are run – and with it the potential to make health equity a reality.

The post Agents of change: How the Gen Z medical science liaison will transform healthcare appeared first on MedCity News.

Taking steps to eliminate health disparities among people of color and ensuring diversity throughout the development cycle should be a strategic goal for all. Medical Affairs can be the change agents within their organizations to help with this push.

The post Key metrics for successful D&I in the drug development lifecycle appeared first on MedCity News.

To achieve diversity goals in research requires a multifaceted approach that makes clinical trial participation easier and uses analytics to help identify the right patients to recruit for a clinical trial.

The post Lack of diversity in clinical trials isn’t just a recruiting problem—it’s a data problem appeared first on MedCity News.

Underrepresented groups traditionally were thought to have limited access to technology. But internet access is on the rise and researchers can take steps to increase participant diversity and be more inclusive.

The post Technology considerations to promote inclusion, equity and diversity in clinical research appeared first on MedCity News.

Whether seeking to overcome ongoing hesitation of the Covid-19 vaccine or searching for moonshot cancer solutions, whatever the healthcare need demands, seeking results for diverse populations must be a priority.

The post Restoring trust in clinical trials among Black communities appeared first on MedCity News.

The company rolled out a tool to help pharmaceutical companies pull together information about clinical trial sites and identify the best physician investigators for a trial.

The post To make trials more inclusive, H1 wants to help find the right physicians appeared first on MedCity News.

The collaborative community, launched by MedTech Color in May, is bringing together industry stakeholders and FDA representatives to increase diversity in all aspects of medical device development, from hiring researchers to recruiting patients for clinical trials.  

The post Medtech leaders launch FDA-backed initiative to bolster diversity in device development appeared first on MedCity News.

CVS Health has launched a new clinical trials services business that will help drug companies and contract research organizations recruit clinical trial volunteers. The new business unit builds on work the pharmacy giant did last year, identifying and recruiting people for studies testing Covid-19 vaccines and medicines.

The post CVS joins the decentralized clinical trials movement with launch of new biz unit appeared first on MedCity News.

The Covid-19 pandemic is altering behavior and fueling demand for remote technologies in clinical trials with Medable, a company in the clinical trial software space, looking to capitalize.

The post Investors pour $91M into growing clinical-trial software firm appeared first on MedCity News.

The company plans to train 250 new racially and ethnically diverse clinical trial investigators and extend the reach of its trials to underserved rural and urban communities.

The post BMS puts $300M toward diversity efforts, including clinical trial diversity appeared first on MedCity News.

In a commentary, physicians and pharmacists wrote that percentages of Black, Latino and Native American patients in two Phase III studies of the drug that the company is using for FDA approval were disproportionate to Covid-19’s incidence in those communities.

The post Trials of Gilead’s remdesivir in Covid-19 not diverse enough, experts write appeared first on MedCity News.

If used mindfully, the latest advances in technology could create a more comfortable environment in which we can begin to bring in underrepresented populations and reverse the lack of diversity in clinical trials.

The post Leveraging technology and digital tools to (finally) increase diversity in clinical trials appeared first on MedCity News.